Additional file 1 of Clinical implications of circulating tumor DNA in predicting the outcome of diffuse large B cell lymphoma patients receiving first-line therapy
Additional file 1: Table S1. Gene list of Onco-LymScan panel. Table S2. Overview of patient characteristics. Table S3. Demographic of patient characteristics. Table S4. Sequencing quality data of tumor gDNA samples. Table S5. Sequencing quality data of cfDNA samples. Table S6. Univariate Cox proportional hazard regression survival analysis including pretreatment ctDNA levels and other clinical indices.
figshare Academic Research System
Zhao, Dandan; Li, Miaomiao; Yang, Quanyu; Ma, Tonghui; Ye, Yingying; Wang, Dedao; Zhu, Jun; Cao, Jiaowu; Mi, Lan; Song, Yuqin; Qi, Fei; Zhu, Jianhua; Wang, Chunyang; Hu, Dingyao; Yu, Hui; Wang, Xiaojuan (2022), "Additional file 1 of Clinical implications of circulating tumor DNA in predicting the outcome of diffuse large B cell lymphoma patients receiving first-line therapy", figshare Academic Research System, doi: 10.6084/m9.figshare.21393919